Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Eye Neoplasms × Laparotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Uveal Melanoma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Hyperthermia 1 Fallopian Tube Neoplasms 1 Eye Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Burkitt Lymphoma 1

Interventions

montanide ISA 51 1 Proton Therapy 1 Peptides 1 Melphalan 1 MART-1 Antigen 1 MAGEA3 protein, human 1 Leuprolide 1 Laparotomy 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00062933 2012-08-20

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Hyperthermia, Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡